Status:
COMPLETED
Evaluation of the Intubating Laryngeal Airway in Children
Lead Sponsor:
University of British Columbia
Conditions:
Intubating Laryngeal Airway
Eligibility:
All Genders
Up to 16 years
Brief Summary
The Air-Q® intubating laryngeal airway (Air-Q® ILA) is an extraglottic device specifically engineered for use both as a stand-alone laryngeal mask airway (LMA) and as a rescue device or "Plan B" devic...
Detailed Description
Hypothesis: The Air-Q® intubating laryngeal airway (Air-Q® ILA) will: (1) perform satisfactorily as a primary airway; (2) perform comparably or better than the ProSeal™ LMA (PLMA); and (3) act as an e...
Eligibility Criteria
Inclusion
- ASA I-III
- Ideal body weight as determined from weight/height centile curves (\> 3rd \& \< 97th centiles)
- Elective surgery
- Appropriate subject and procedure for airway management by LMA
Exclusion
- ASA status IV-V
- Emergency surgery
- Abnormal or contraindicated cervical spine flexion/extension/rotation
- Contraindication to LMA placement:
- Aspiration risk; gastro-oesophageal reflux disease
- Clinically significant pulmonary disease
- Coagulopathy
- Distorted airway anatomy judged likely to compromise LMA placement
- Allergy to any LMA components
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT00885911
Start Date
March 1 2009
End Date
September 1 2012
Last Update
June 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
British Columbia Children's Hospital Department of Anesthesia
Vancouver, British Columbia, Canada, V6H 3V4